Generated by DeepSeek V3.2| translation (biology) | |
|---|---|
| Name | Translation |
| Part of | Gene expression |
| Location | Cytoplasm, Endoplasmic reticulum |
| Reactants | Messenger RNA, Transfer RNA, Amino acids |
| Products | Polypeptide chain |
| Enzyme | Ribosome |
translation (biology). In molecular biology, translation is the cellular process in which the sequence of a Messenger RNA molecule is decoded by a Ribosome to produce a specific Polypeptide chain. This process is a fundamental step in Gene expression, following Transcription (biology), and is essential for the synthesis of functional Proteins. The machinery reads the Genetic code in sets of three Nucleotides, known as Codons, each specifying a particular Amino acid.
Translation is a core biological process that occurs in all living cells, converting genetic information into functional molecules. It is a key stage in the Central dogma of molecular biology, which outlines the flow of information from DNA to RNA to protein. The process is highly conserved across Eukaryotes, Prokaryotes, and Archaea, though with notable differences in initiation factors and regulatory mechanisms. The primary site of translation is the Cytoplasm, though in eukaryotic cells, ribosomes bound to the Endoplasmic reticulum synthesize proteins destined for secretion or membrane insertion.
The genetic code is the set of rules by which information encoded within Messenger RNA is translated into the amino acid sequence of a protein. It was deciphered through pioneering work by scientists like Marshall Nirenberg, Har Gobind Khorana, and Robert W. Holley, who were awarded the Nobel Prize in Physiology or Medicine in 1968. The code is composed of Codons, each a triplet of Nucleotides, with 61 sense codons specifying the 20 standard Amino acids and 3 Stop codons signaling termination. This code is nearly universal, with minor variations found in the mitochondria of some organisms and in certain Protozoa.
The molecular machinery of translation is complex and involves multiple coordinated components. The central player is the Ribosome, a large Ribonucleoprotein complex composed of Ribosomal RNA and proteins, whose structure was elucidated by Ada Yonath, Thomas Steitz, and Venkatraman Ramakrishnan, earning them the Nobel Prize in Chemistry in 2009. Transfer RNA molecules, each charged with a specific amino acid by enzymes called Aminoacyl tRNA synthetases, deliver their cargo to the ribosome. The process occurs in three stages: initiation, guided by factors like EIF2 in eukaryotes; elongation, catalyzed by Peptidyl transferase; and termination, triggered when a release factor recognizes a Stop codon.
Regulation of translation is a critical control point in gene expression, allowing cells to rapidly respond to environmental cues and developmental signals. Key mechanisms include the phosphorylation of initiation factors such as EIF2 by kinases like PKR, which can globally downregulate protein synthesis during cellular stress. Specific regulation is often achieved through sequences in the Untranslated region of the Messenger RNA that interact with RNA-binding proteins or MicroRNA complexes, as studied by researchers like Victor Ambros and Gary Ruvkun. In prokaryotes, translational control is exemplified by the operon model first described by François Jacob and Jacques Monod.
Following translation, most Polypeptide chains undergo various post-translational modifications to become fully functional Proteins. These modifications, which occur in compartments like the Endoplasmic reticulum and Golgi apparatus, include proteolytic cleavage, as seen in the activation of Insulin or Zymogens. Other common modifications are Phosphorylation, often mediated by Kinases such as those discovered by Edmond H. Fischer and Edwin G. Krebs; Glycosylation; and the formation of Disulfide bonds. These alterations can affect a protein's activity, localization, stability, and interactions, as demonstrated in the maturation of Collagen or the regulation of P53.
Dysregulation or errors in translation have profound clinical significance and are implicated in numerous diseases. Many Antibiotics, such as Streptomycin and Erythromycin, target the bacterial Ribosome, exploiting differences from eukaryotic ribosomes to treat infections. Genetic disorders like Diamond–Blackfan anemia are linked to mutations in Ribosomal protein genes. Furthermore, aberrant translational control is a hallmark of many Cancers, with oncogenes like MYC driving increased ribosome biogenesis. Research into Antisense oligonucleotide therapies and RNA interference, pioneered by scientists like Andrew Fire and Craig Mello, also aims to modulate translation for therapeutic benefit.
Category:Molecular biology Category:Gene expression Category:Protein biosynthesis